Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
State Street SPDR S&P Biotech ETF is hovering above a buy point after breaking out. The post Analysts See Drastic Change For This Particular Part Of Healthcare appeared first on Investor’s Business Daily.
Biotech stock TG Therapeutics is building a cup base after a sell-off in early August. It is testing a key moving average. The post TGTX Stock Outperforms 95% of Stocks. Here’s Why. appeared first on Investor’s Business Daily.
Travere Therapeutics is Friday’s IBD Stock Of The Day. As the Filspari story gets “sweeter,” shares are clearing a fresh buy point. The post IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any ‘Sweeter?’…
These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 months. The post Three Biotech Stocks Stick Out With Their Stellar Charts appeared first on Investor’s Business Daily.
Moderna stock could catch the eye of investors looking for the next big AI play, Revere Asset Management’s Don Vandenbord says. The post Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into Biotech appeared first on Investor’s…
The biggest names behind biotech stocks are investing richly in artificial intelligence with the goal of speeding up drug development. The post Making Drugs With AI: Biopharma Giants Gear Up For New Arena appeared first on Investor’s Business Daily.
Sales of Kiniksa Pharmaceuticals’ biggest product, Arcalyst, are expected to begin declining in 2030. But the company has a plan. The post Kiniksa’s Sales Are Expected To Decline — Why That’s All According To Plan appeared first on Investor’s Business Daily.
Eli Lilly stock broke out of a flat base and reached a record high. Its Mounjaro drug sales surged 91% in the second quarter. The post Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The…
After skyrocketing 1,027% off a low, Relay Therapeutics taps AI and machine learning to fuel more gains. The post This ‘Dynamo’ Biotech Puts AI-Fueled Breakout In Motion appeared first on Investor’s Business Daily.
MarketSurge data shows short interest in Moderna was 6.9 times the stock’s daily average share turnover. The post Stock Market Rises, But Sellers Hit Some Leaders; Trump Move Shoots Holes Through This Industry appeared first on Investor’s Business Daily.
